Skip to main content
This block is broken or missing. You may be missing content or you might need to enable the original module.
Search
Main sub menu
Investors
Careers
Working at Recipharm
The Recipharm story
Meet our employees
Current vacancies
Contact
Contact us
Development services contacts
Manufacturing services contacts
Locations
France
Fontaine
Kaysersberg
Monts
Pessac
Germany
Monheim
Wasserburg
Zwickau
India
Bengaluru
Karnal / Paonta Sahib
Israel
Ness Ziona
Italy
Brescia
Lainate
Masate
Paderno Dugnano
Pianezza
Portugal
Odivelas
Queluz
Spain
Parets
Leganés
Sweden
Höganäs
Stockholm city (HQ)
Karlskoga
Solna
Stockholm
Strängnäs
Uppsala
Uppsala Development
UK
Ashton
Cramlington
Holmes Chapel
Queenborough
USA
Research Triangle Park
Main navigation
Development
Drug substance
Drug product
Analytical chemistry
Clinical trial material (CTM)
Manufacturing
Solids
Semi-solids
Liquids
Inhalation
Injectables
Ophthalmics
Solutions
Recipharm Analytical Solutions™
Recipharm Inhalation Solutions™
Recipharm Pathway to Clinic®
Serialisation
Bespak
Learn
Press & events
Press
Events
Reports
Insights
Our story
Recipharm in brief
Business model
Business overview
Sustainability
Company history
Press & events
What's happening?
Stay updated on our latest news and events.
Press and Event
Press
Events
Reports
Insights
Displaying 181 - 190 of 356
Subscribe
Show all
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Press
Recipharm in discussions with Alcon regarding long-term manufacturing agreement
2015.09.07
Read more
Press
Recipharm Signs Agreement with RedHill Biopharma for Manufacturing of RHB-105 for treatment of H. pylori infection
2015.08.26
Read more
Press
Change in the total number of shares and votes in Recipharm AB (publ)
2015.07.31
Read more
Press
Interim report January-June 2015
2015.07.23
Read more
Press
Invitation to presentation of Recipharm’s interim report for the first quarter on 23 July 2015
2015.07.20
Read more
Press
Recipharm secures additional bank financing for continued growth
2015.07.13
Read more
Press
Recipharm invests SEK 8 million in Pharmanest to support the development of Pharmanest’s lead drug candidate SHACT
2015.07.09
Read more
Press
Recipharm Reduces Risk and Improves Compliance with Infor
2015.07.07
Read more
Press
Change in the total number of shares and votes in Recipharm AB (publ)
2015.06.30
Read more
Press
Recipharm appoints new Sales Director, Development Services
2015.06.29
Read more
Pagination
First page
« First
Previous page
‹ Previous
…
Page
15
Page
16
Page
17
Page
18
Current page
19
Page
20
Page
21
Page
22
Page
23
…
Next page
Next ›
Last page
Last »